Pharmacologic Analysis of Platelet Activating Factor16‐ and 18‐Induced Bronchoconstriction in the Guinea Pig

Annals of the New York Academy of SciencesVolume 629, Issue 1 p. 176-192 Pharmacologic Analysis of Platelet Activating Factor16- and 18-Induced Bronchoconstriction in the Guinea Pig ROBERT D. KRELL, ROBERT D. KRELL ICI Pharmaceuticals Group Department of Pharmacology Pulmonary Section Wilmington, Delaware 19897Search for more papers by this authorMICHELLE McCARTHY, MICHELLE McCARTHY ICI Pharmaceuticals Group Department of Pharmacology Pulmonary Section Wilmington, Delaware 19897Search for more papers by this author ROBERT D. KRELL, ROBERT D. KRELL ICI Pharmaceuticals Group Department of Pharmacology Pulmonary Section Wilmington, Delaware 19897Search for more papers by this authorMICHELLE McCARTHY, MICHELLE McCARTHY ICI Pharmaceuticals Group Department of Pharmacology Pulmonary Section Wilmington, Delaware 19897Search for more papers by this author First published: July 1991 https://doi.org/10.1111/j.1749-6632.1991.tb37975.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Braquet, P., L. Touqui, T. Y. Shen & B. B. Vargaftig. 1987. Perspectives in platelet-activating factor research. Pharmacol. Rev. 39: 97–145. CASPubMedWeb of Science®Google Scholar 2 Robertson, D. N. & C. P. Page. 1987. Effect of platelet agonists on airway reactivity and intrathoracic platelet accumulation. Br. J. Pharmacol. 92: 105–111. 10.1111/j.1476-5381.1987.tb11301.x CASPubMedWeb of Science®Google Scholar 3 Dixon, E. J. A., P. Wilsoncroft, D. N. Robertson & C. P. Page. 1989. The effect of PAF antagonists on bronchial hyperresponsiveness induced by PAF, propranolol or indomethacin. Br. J. Pharmacol. 97: 717–722. 10.1111/j.1476-5381.1989.tb12008.x PubMedWeb of Science®Google Scholar 4 Chung, K. F., H. Aizawa, G. D. Leikauf, I. F. Ueki, T. W. Evans & J. A. Nadel. 1985. Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. J. Pharmacol. Exp. Ther. 236: 580–584. PubMedWeb of Science®Google Scholar 5 Cuss, F. M., C. M. S. Dixon & P. J. Barnes. 1986. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 189–192. Google Scholar 6 Rubin, A-H. E., L. J. Smith & R. Patterson. 1987. The bronchoconstrictor properties of platelet-activating factor in humans. Am. Rev. Resp. Dis. 136: 1145–1151. 10.1164/ajrccm/136.5.1145 CASPubMedWeb of Science®Google Scholar 7 Townley, R. G., R. J. Hopp, D. K. Agrawal & A.K. Bewtra. 1989. Platelet-activating factor and airway reactivity. J. Allergy Clin. Immunol. 83: 997–1010. 10.1016/0091-6749(89)90437-5 CASPubMedWeb of Science®Google Scholar 8 Vargaftig, B. B., J. Lefort, M. Chignard & J. Benveniste. 1980. Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur. J. Pharmacol. 65: 185–192. 10.1016/0014-2999(80)90391-X CASPubMedWeb of Science®Google Scholar 9 Vargaftig, B. B., J. Lefort, F. Wal, M. Chignard & M. C. Medeiros. 1982. Non-steroidal anti-inflammatory drugs if combined with anti-histamine and anti-serotonin agents interfere with the bronchial and platelet effects of “platelet-activating factor” (PAF-ACETHER). Eur. J. Pharmacol. 82: 121–130. PubMedWeb of Science®Google Scholar 10 Iwana, T., K-I. Shikada & S. Tanaka. 1988. Pharmacological modulation of platelet activating factor (PAF)-induced bronchoconstriction and hypertension in anaesthetized guinea-pigs. J. Pharm. Pharmacol. 40: 544–547. 10.1111/j.2042-7158.1988.tb05299.x PubMedWeb of Science®Google Scholar 11 Christman, B. W., P. L. Lefferts, G. A. King & J. R. Snapper. 1988. Role of circulating platelets and granulocytes in PAF-induced pulmonary dysfunction in awake sheep. J. Appl. Physiol. 64: 2033–2041. CASPubMedWeb of Science®Google Scholar 12 Evans, T. W., K. F. Chung, D. F. Rogers & P. J. Barnes. 1987. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. J. Appl. Physiol. 63: 479–484. CASPubMedWeb of Science®Google Scholar 13 Gamse, R., A. Wax, R. E. Zigmond & S. E. Leeman. 1981. Immunoreactive substance P in sympathetic ganglia: distribution and sensitivity towards capsaicin. Neuroscience 6: 437–441. 10.1016/0306-4522(81)90136-6 CASPubMedWeb of Science®Google Scholar 14 Pretolani, M., J. Lefort, E. Malanchére & B. B. Vargaftig. 1987. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs. Eur. J. Pharmacol. 140: 311–321. PubMedWeb of Science®Google Scholar 15 Terashita, Z-I., Y. Imura, M. Takatani, S. Tsushima & K. Nishikawa. 1987. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo. J. Pharmacol. Exp. Ther. 242: 263–268. CASPubMedWeb of Science®Google Scholar 16 Handley, D. A., R. G. Van Valen, J. C. Tomesch, M. K. Melden, J. M. Jaffe, F. H. Ballard & R. N. Saunders. 1987. Biological properties of the antagonist SRI 63–441 in the PAF and endotoxin models of hypotension in the rat and dog. Immunopharmacology 13: 125–132. 10.1016/0162-3109(87)90049-X CASPubMedWeb of Science®Google Scholar 17 Krell, R. D., R. E. Giles, Y. K. Yee & D. W. Synder. 1987. In vivo pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist. J. Pharmacol. Exp. Ther. 243: 557–564. CASPubMedWeb of Science®Google Scholar 18 Snyder, D. W., R. E. Giles, R. A. Keith, Y. K. Yee & R. D. Krell. 1987. In vitro pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist. J. Pharmacol. Exp. Ther. 243: 548–556. CASPubMedWeb of Science®Google Scholar 19 Skidgel, R. A., S. Engelbrecht, A. R. Johnson & E. G. Erdös. 1984. Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase. Peptides 5: 769–776. 10.1016/0196-9781(84)90020-2 CASPubMedWeb of Science®Google Scholar 20 Stimler-Gerard, N. 1987. Neutral endopeptidase-like enzyme controls the contractile activity of substance P in guinea pig lung. J. Clin. Invest. 79: 1819–1825. 10.1172/JCI113023 CASPubMedWeb of Science®Google Scholar 21 Hooper, N. M., A. J. Kenney & A. J. Turner. 1985. The metabolism of neuropeptides: neurokinin A (substance K) is a substrate for endopeptidase-24.11 but not for peptidyl dipeptidase A (angiotensin-converting enzyme). Biochem. J. 231: 357–361. 10.1042/bj2310357 CASPubMedWeb of Science®Google Scholar 22 Roques, B. P. M. C. Fournié-Zaluski, E. Saroca, J. M, Lecomte, B. Malfroy, C. Liorens & J. C. Schwartz. 1980. The enkephalinase inhibitor thiorphan shows antinociceptive in mice. Nature 20: 286–288. 10.1038/288286a0 Web of Science®Google Scholar 23 Chand, N., J. Pillar, K. Nolan, W. Diamantis & R. D. Sofia. 1990. Inhibition of PAF-induced histamine secretion and bronchoconstriction by WEB 2086. Res. Commun. Chem. Pathol. Pharmacol. 67: 155–158. PubMedWeb of Science®Google Scholar 24 Bonnet, J., D. Thibaudeau & P. Bessin. 1983. Dependency on the PAF-acether induced bronchospasm on the lipoxygenase pathway in the guinea pig. Prostaglandins 26: 457–466. 10.1016/0090-6980(83)90180-6 CASPubMedWeb of Science®Google Scholar 25 Buckner, C. K., D. Dea, N. Liberati & R. D. Krell. A pharmacologic examination of receptors mediating serotonin-induced bronchoconstriction in the anesthesized guinea pig. J. Pharmacol. Exp. Ther. In press. PubMedGoogle Scholar 26 Baumgartner, R. A., M. Wills-Karp, M. J. Kaufman, M. Munakata & C. Hirshman. 1990. Serotonin induces constriction and relaxation of guinea pig airway. J. Pharmacol. Exp. Ther. 255: 165–173. CASPubMedWeb of Science®Google Scholar Citing Literature Volume629, Issue1Advances in the Understanding andTreatment of AsthmaJuly 1991Pages 176-192 ReferencesRelatedInformation